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Prognostic Role of Pulmonary Arterial Capacitance in
Advanced Heart Failure
Matthias Dupont, MD; Wilfried Mullens, MD, PhD; Hadi N. Skouri, MD; Zuheir Abrahams, MD, PhD;
Yuping Wu, PhD; David O. Taylor, MD; Randall C. Starling, MD, MPH; W. H. Wilson Tang, MD
Background—Right ventricular (RV) dysfunction frequently occurs and independently prognosticates in left-sided heart
failure. It is not clear which RV afterload measure has the greatest impact on RV function and prognosis. We examined the
determinants, prognostic role, and response to treatment of pulmonary arterial capacitance (PAC, ratio of stroke volume
over pulmonary pulse pressure), in relation to pulmonary vascular resistance (PVR) in heart failure.
Methods and Results—We reviewed 724 consecutive patients with heart failure who underwent right heart catheterization between
2000 and 2005. Changes in PAC were explored in an independent cohort of 75 subjects treated for acute decompensated heart
failure. PAC showed a strong inverse relation with PVR (r=−0.64) and wedge pressure (r=−0.73), and provides stronger
prediction of signiﬁcant RV failure than PVR (area under the curve ROC 0.74 versus 0.67, respectively, P=0.003). During
a mean follow-up of 3.2±2.2 years, both lower PAC (P<0.0001) and higher PVR (P<0.0001) portend more adverse clinical
events (all-cause mortality and cardiac transplantation). In multivariate analysis, PAC (but not PVR) remains an independent
predictor (Hazard ratio=0.92 [95% CI: 0.84–1.0, P=0.037]). Treatment of heart failure resulted in a decrease in PVR (270±165
to 211±88 dynes·s–1·cm–5, P=0.002), a larger increase in PAC (1.65±0.64 to 2.61±1.42 mL/mm Hg, P<0.0001), leading to an
increase in pulmonary arterial time constant (PVR×PAC) (0.29±0.12 to 0.37±0.15 second, P<0.0001).
Conclusions—PAC bundles the effects of PVR and left-sided ﬁlling pressures on RV afterload, explaining its strong relation
with RV dysfunction, poor long-term prognosis, and response to therapy. (Circ Heart Fail. 2012;5:778–785.)

T

here has been increasing recognition regarding the importance of right ventricular (RV) dysfunction as an independent determinant of poor prognosis and exercise intolerance
in patients with left-sided heart failure.1–7 In particular, RV
function correlates better with exercise capacity than left ventricular function.4,8 There are several potential mechanisms
that may contribute to deteriorating RV that may ultimately
become dysfunctional in association with left ventricular
(LV) failure. First, it can suffer from the same cardiomyopathic process as the left ventricle. Second, decreased coronary
perfusion, LV dilatation in a limited pericardial compartment
(ventricular interdependence), and septal dysfunction can all
alter RV systolic and diastolic properties. Finally, LV failure
can directly increase RV afterload through a passive (pulmonary venous pressure elevation) and reactive (pulmonary
vasoconstriction and remodeling) component, thus putting the
afterload-sensitive RV at increased risk of failure even in the
absence of intrinsic damage.9,10 It is however unclear whether
pulmonary vascular resistance (PVR) is the best reﬂection of
RV afterload in the setting of left-sided heart failure.

Pulmonary arterial capacitance (PAC), deﬁned as the
ratio of stroke volume over pulmonary pulse pressure, is a
recently proposed determinant of RV afterload. It represents
the distensibility of the pulmonary arterial tree and has shown
to be a better predictor of mortality than PVR in pulmonary
arterial hypertension (PAH).11,12 Likewise, the importance
of compliance, as a predictor of adverse events, has been
demonstrated in the systemic circulation. In healthy individuals
and in patients with PAH, it has been demonstrated that PVR
and PAC are inversely related in such way that their product
forms a constant.13 This even holds true during treatment
for PAH.14–16 This implies that early in the course of PAH,
small increases in PVR are accompanied by large decreases
in PAC, likely accounting for the superior prognostic ability
of the latter. In PAH however, the primary pathology lies in
the remodeling of the small arteries and arterioles, whereas
in heart failure the primary pathology is localized in the left
ventricle with subsequent rise in ﬁlling pressures. Remodeling
or constriction of small pulmonary arteries are possibilities,
but not requisites. Very recently, Tedford et al described
the inﬂuence of wedge pressure and age on the relationship
between PAC and PVR.17

The aims of this study were: (1) To determine relationships
between PAC and various clinical, hemodynamic, and echocardiographic variables; (2) To investigate whether the inverse
relationship between PAC and PVR remains valid in the setting of (left-sided) heart failure; (3) To test which afterload
measure (PVR or PAC) best correlates with RV failure; (4)
To test which afterload measure (PVR or PAC) best predicts
outcomes; and (5) To determine whether PAC is modiﬁable
during treatment of acute decompensated heart failure.

Methods
Study Population
We reviewed clinical information for all consecutive patients aged
18 years or older with advanced chronic (>6 months) heart failure
who underwent right heart catheterization between January 1, 2000
and August 31, 2005 in the Cleveland Clinic cardiac catheterization
laboratory. The primary indication for right heart catheterization was
worsening heart failure symptoms or as part of a workup for heart
transplant candidacy. Patients were excluded if they had a diagnosis
of PAH, were on chronic inotropic drug infusions or had complex
congenital heart disease.
To explore whether PAC could be modiﬁed during treatment, we
examined a separate cohort of consecutive acute decompensated
heart failure patients admitted to the Cleveland Clinic for hemodynamically tailored therapy between December 1, 2010 and September
30, 2011. We included all patients whose pulmonary capillary wedge
pressure (PCWP) decreased 10 mm Hg or more during treatment
on serial measurements. The Cleveland Clinic Institutional Review
Board has approved this study.

Hemodynamic Assessment
Right heart catheterization was done in the catheterization laboratory
at rest in the supine position. The procedure was performed by a heart
failure fellow in the presence of a member of the heart failure staff
cardiologist. The internal venous jugular approach was commonly
used. A balloon-tipped catheter was used to obtain mean right atrial
pressure, pulmonary artery systolic and diastolic pressures, as well as
PCWP. All measurements were obtained at end expiration at steady
state with the patient in a supine position. PCWP was calculated by
the computer as the integrated mean. Mixed central venous blood gas
was sampled from the pulmonary artery. Cardiac output was measured by assumed Fick equation. PVR and systemic vascular resistance, cardiac index, stroke volume, and transpulmonary gradient
were calculated using the standard formulas. Systolic and diastolic
blood pressures were obtained using a digital sphygmomanometer at
the time of the procedure. PAC is directly related to the volume of
forward ﬂow (ie, stroke volume) and inversely proportional to the
pulmonary artery pulse pressure (ie, difference between pulmonary
artery systolic and diastolic pressures), according to the following
equation: PAC=Stroke volume/pulse pressure and expressed in mL/
mm Hg. The product of resistance and capacitance (PVR×PAC) is
referred to as the pulmonary arterial time constant τ.
Besides the hemodynamic variables, demographic characteristics,
medical history, medical treatment, implanted devices, and echocardiographic parameters (if done within 30 days before the catheterization procedure) were also collected. LV ejection fraction was
measured by biplane Simpson’s method, mitral and tricuspid regurgitation were semiqualitatively graded by color-ﬂow Doppler in the
conventional parasternal long-axis and apical 4-chamber images:
minimal: 1+ (jet area/left atrial area <10%); moderate: 2+ (jet area/
left atrial area 10%–20%); moderate-severe: 3+ (jet area/left atrial
area 20%– 45%); or severe: 4+ (jet area/left atrial area >45%). RV
systolic dysfunction was visually assessed on a scale of 0 to 4, with 0
being normal and 4 being severely hypokinetic RV wall motion. RV
failure was deﬁned as grade 3 or 4 hypokinetic motion.
The duration of follow-up was deﬁned as the interval from the index right heart catheterization date to December 31, 2006. Manual

chart review for all-cause mortality and transplantation was performed, and review of the Social Security Death Index conﬁrmed
the death status. All-cause mortality and cardiac transplantation were
combined as the prespeciﬁed primary outcome for survival analysis.
For the second set of patients with serial assessment, 2 sets of hemodynamics (on admission and at time of pulmonary artery catheter
removal) were used for this analysis. The hemodynamic values were
documented in the chart by other cardiologists who were unaware of
the present study, after careful leveling of the transducer. In addition,
demographics and treatment data were abstracted from the chart.

Statistical Methods
The data are expressed as mean±SD for continuous data and as a
percentage for categorical data. Comparisons are made with the use
of the Student t test or Wilcoxon rank sum test. A paired t test was
used to detect changes in PVR, PAC, or τ after treatment. The distribution of PAC was asymmetric and therefore expressed as median
and interquartile range. Spearman correlation coefﬁcients were used
to assess the univariate relationships between PVR/PAC and clinical, hemodynamic, and echocardiographic variables. To demonstrate
the relationship between PVR and PAC, a nonlinear curve was ﬁtted
according to the formula y=cte/x (hyperbola formula). Receiver operating characteristic (ROC) curves were constructed to examine the
association between different afterload measures and coinciding RV
failure. The Cox proportional hazards regression model was used to
determine which variables were signiﬁcant predictors for all-cause
mortality and cardiac transplantation during the mean 3.2±2.2 years
follow-up period. A multivariate model was constructed using wellknown predictors of adverse outcomes in heart failure (age, New York
Heart Association [NYHA] class, RV function, cardiac index, and
glomerular ﬁltration rate) in addition to one of the afterload parameters. Study population was stratiﬁed into PAC and PVR quartiles to
facilitate identiﬁcation of high and low risk patients by Kaplan-Meier
survival analysis. Statistical signiﬁcance was set at a 2-tailed probability level of <0.05. All analyses were performed with SAS version
9.1 and JMP version 5.1 (SAS Institute Inc, Cary, NC). The authors
had full access to the data and take responsibility for its integrity. All
authors have read and agreed to the manuscript as written.

Results
Baseline Characteristics
A total of 724 patients, for whom hemodynamic data were
available, underwent right heart catheterization between January 1, 2000 and August 31, 2005. The mean and median PAC
was, respectively, 3.07±2.05 mL/mm Hg and 2.5 (interquartile range 1.60–3.96) mL/mm Hg. Table 1 shows the baseline
characteristics of our study cohort stratiﬁed according to those
above versus below median PAC levels. Patients with reduced
PAC were older, had more impaired hemodynamics and
impaired cardiac performance by echocardiography (available
in 650 patients, 90%).

Correlations Between PAC, PVR, and
Other Variables
Table 2 illustrates correlations between PAC, PVR, and various
clinical, hemodynamic, and echocardiographic variables in
our study cohort. PAC highly correlates with PCWP (r=−0.73,
P<0.0001) and mean pulmonary artery pressure (r=−0.81,
P<0.0001). The correlation coefﬁcients of PAC were larger (in
absolute magnitude) than those of PVR when correlated with
different measures of RV failure such as RV dysfunction class
(r=−0.46 versus r=0.32), tricuspid insufﬁciency (r=−0.37
versus r=0.25), and right atrial pressure (r=−0.51 versus

Table 1.

Baseline Patient Characteristics Stratiﬁed According to Median PAC Levels
Total Population (n=724)

PAC >2.5 mL/mm Hg (n=362)

PAC ≤2.5 mL/mm Hg (n=362)

P

Baseline clinical data
Age, y

55±11

53±12

56±11

<0.0001

Sex (% male)

77

77

78

1.00

Ischemic pathogenesis, %

50

49

51

0.43

28±5

29±6

28

24

31

0.031

81±19

78±18

84±19

<0.0001

2

Body mass index, kg/m
Diabetes mellitus, %

27±5

0.0036

Hemodynamic data
Heart rate, bpm
Mean arterial pressure, mm Hg

85±13

84±12

87±13

0.0053

Mean RA pressure, mm Hg

8.9±5.9

6.6±5.1

11.2±5.7

<0.0001

Mean PA pressure, mm Hg

30±11

22±8

37±9

<0.0001

Pulse pressure, mm Hg

24±10

17±6

31±9

<0.0001
<0.0001

PCWP, mm Hg
Transpulmonary gradient, mm Hg

19±9

14±7

25±7

10.4±5.9

8.1±4

12.6±7

<0.0001

Fick cardiac index, L·min–1·m–2

2.3±0.6

2.6±0.6

2.0±0.5

<0.0001

Stroke volume

59±20

70±20

48±14

<0.0001

PVR, dynes·s ·cm

–5

208±141

138±72

279±158

<0.0001

SVR, dynes·s–1·cm–5

1496±468

1324±394

1670±473

<0.0001

578±263

507±231

648±275

<0.0001
<0.0001

–1

RVSWI, mL·mm Hg–1·m–2
Echocardiographic data
LV ejection fraction, %

19±9

21±10

17±8

LV end-diastolic diameter, mm

6.6±1.1

6.5±1.1

6.7±1.1

0.018

48

29

66

<0.0001

RV systolic pressure, mm Hg

46±17

34±10

58±13

<0.0001

Mitral regurgitation ≥3+, %

33

23

43

<0.0001

Tricuspid regurgitation ≥3+, %

19

12

25

<0.0001

ACE inhibitor or ARBs, %

86

87

84

0.04

β-blockers, %

69

72

66

0.11

Loop diuretics, %

92

89

95

0.004

Aldosterone antagonists, %

37

34

39

0.14

38

38

38

0.93

9

7

10

0.18

71±28

74±28

68±27

0.008

RV function class ≥3+, %

Medications

Device data
ICD, %
CRT-D, %
Laboratory data
eGFR (mL·mm Hg–1·m–2, n=664)
BNP (pg/mL, n=207)

730±872

476±818

981±845

<0.0001

Hemoglobin (g/dL, n=667)

13.4±1.8

13.6±1.6

13.1±1.9

0.0004

PAC indicates pulmonary arterial capacitance; bpm, beats per minute; RA, right atrial; PA, pulmonary arterial; PCWP, pulmonary capillary wedge pressure; PVR,
pulmonary vascular resistance; SVR, systemic vascular resistance; RVSWI, right ventricular stroke work index; LV, left ventricular; RV, right ventricular; ACE, angiotensinconverting enzyme; ARB, angiotensin receptor blocker; ICD, implantable cardioverter-deﬁbrillator; CRT-D, cardiac resynchronization therapy with deﬁbrillator; eGFR,
estimated glomerular ﬁltration rate; BNP, B-type natriuretic peptide.

r=0.31). As expected, there is a strong, although not perfect,
negative correlation between the 2 afterload measures PAC and
PVR (r=−0.66, P<0.0001). Figure 1 plots PAC as a function of
PVR and demonstrates their hyperbolic relationship. However,
the exact shape of the hyperbola, and thus the pulmonary
arterial time constant τ=PVR×PAC, decreases with increasing
wedge pressure (r=−0.42, P<0.0001) (Figures 1 and 2). When
dichotomized at a wedge pressure of ≤ or >17 mm Hg, the
mean pulmonary arterial time constant τ decreases from

0.43 to 0.30 seconds. Of note, the correlation between mean
pulmonary pressure and τ (r=−0.11) is much lower than the
correlation between wedge pressure and τ.

Association of RV Failure With Different
Afterload Measures
RV failure, as deﬁned by echocardiographic dysfunction
grade 3 or more, was very frequent (312/650 patients [48%]
with available echocardiograms). The association of PAC with

Table 2. Spearman Correlation Coefﬁcients Between PAC and PVR on One Hand and Various Clinical,
Hemodynamic, and Echocardiographic Variables on the Other
PAC

PVR

Correlation Coefﬁcient

P

Correlation Coefﬁcient

P

−0.21
0.20

<0.0001

0.16

<0.0001

<0.0001

−0.15

<0.0001

−0.24

<0.0001

0.12

0.0009

Heart rate, bpm

−0.22

<0.0001

0.09

0.01

Mean arterial pressure, mm Hg

−0.09

0.019

0.05

0.16

Mean RA pressure, mm Hg

−0.51

<0.0001

0.31

<0.0001

Mean PA pressure, mm Hg

−0.81

<0.0001

0.62

<0.0001

Pulse Pressure, mm Hg

−0.84

<0.0001

0.53

<0.0001

PCWP, mm Hg

−0.73

<0.0001

0.31

<0.0001

Transpulmonary gradient, mm Hg

Baseline clinical data
Age, y
Body mass index, kg/m2
NYHA class
Hemodynamic data

−0.44

<0.0001

0.88

<0.0001

Fick cardiac index, L·min–1·m–2

0.55

<0.0001

−0.40

<0.0001

Stroke volume

0.67

<0.0001

−0.45

<0.0001

−0.64

<0.0001

PAC, ml/mm Hg
PVR, dynes·s–1·cm–5

−0.64

<0.0001

SVR, dynes·s–1·cm–5

−0.49

<0.0001

0.42

<0.0001

RVSWI, mL·mm Hg–1·m–2

−0.25

<0.0001

0.30

<0.0001

−0.19

<0.0001

Echocardiographic data
LV ejection fraction, %

0.29

<0.0001

LV end-diastolic diameter, mm

−0.10

0.014

0.04

0.31

RV systolic dysfunction class

−0.46

<0.0001

0.32

<0.0001

Mitral regurgitation severity

−0.19

<0.0001

0.19

<0.0001

Tricuspid regurgitation severity

−0.37

<0.0001

0.25

<0.0001

Laboratory data
eGFR (mL·min–1·m–2, n=664)
BNP (pg/mL, n=207)
Hemoglobin (g/dL, n=667)

0.17

<0.0001

−0.12

−0.57

<0.0001

0.35

<0.0001

0.002

0.13

0.0007

−0.03

0.39

PAC indicates pulmonary arterial capacitance; PVR, pulmonary vascular resistance; bpm, beats per minute; RA, right atrial; PA, pulmonary arterial; PCWP, pulmonary capillary wedge pressure; SVR, systemic vascular resistance; RVSWI, right ventricular stroke work index; LV, left ventricular; RV, right ventricular; eGFR, estimated glomerular ﬁltration rate; BNP, B-type natriuretic peptide.

RV failure (area under the curve ROC=0.74) was superior
to the association of PVR (area under the curve ROC=0.67,
P=0.003) with RV failure. In comparison, the area under the
curve ROC for wedge pressure is 0.71 (P=0.11 with PAC).
Patients with PAC below the median (<2.5 mL/mm Hg) and
PVR above the median (>170 dynes∙s–1∙cm–5 =2.1 WU) have
an OR of 6.45 (4.35–9.67, P<0.0001) of having RV failure
compared with patients with high PAC (above median) and
low PVR (below median). If PVR was high with preserved
PAC (above median), the OR was 1.94 (1.14–3.28, P=0.02).
However, when PAC was low with preserved PVR (below
median), the OR was 4.45 (2.58–7.80, P<0.0001) again
underscoring the importance of PAC.

transplants (23%) had occurred. Overall, decreasing quartiles of
PAC, PVR, and PCWP were all associated with increasing rates
of death or transplantation (Figure 3; log-rank P<0.0001). In
univariate Cox proportional hazard modeling, PAC was a stronger
predictor of all-cause mortality or transplantation than PVR
(C-statistic 0.69 versus 0.64, P=0.02), whereas the C-statistic for
PCWP was 0.67 (P=0.21 with PAC). In multivariable analysis,
PAC (but not PVR) remained an independent predictor of
adverse clinical events even after adjusting for various clinical,
hemodynamic, and echocardiographic variables including age,
NYHA class, Fick CI, RV function, and estimated glomerular
ﬁltration rate (Table 3). Fick cardiac index, estimated glomerular
ﬁltration rate, and RV systolic function, however, were the
strongest predictors of death or transplantation.

Predictive Capacity of PAC and PVR for
Adverse Events

The Inﬂuence of Treatment on PAC, PVR, and τ

The follow-up period ended at December 31, 2006, after a median
follow-up of a little more than 3 years (1130 days [interquartile
range 382–1883 days]). A total of 224 deaths (31%) and 163

A total of 208 patients were admitted for hemodynamically
tailored therapy between December 1, 2010 and September 30, 2011. Hundred and eighty patients had a PCWP

Figure 1. Inﬂuence of wedge pressure on the hyperbolic relationship between PAC and PVR. Pulmonary arterial capacitance
(PAC) and pulmonary vascular resistance (PVR) relate in such
way that their product forms a constant: PAC×PVR=cte which
equals PAC=cte/PVR, the formula of a hyperbola. The value of
the cte represents the pulmonary arterial time constant. In the
total cohort, the cte which best ﬁts the datapoints is 0.35. However, the value of the pulmonary arterial time constant and so the
shape of the hyperbola depends on wedge pressure. The higher
the wedge pressure, the lower the time constant as illustrated (H0
2 hyperbola’s are similar: P<0.0001).

documented at baseline and at time of catheter removal.
Seventy-ﬁve of those had a decrease in PCWP>10 mm Hg.
Table 4 shows demographic characteristics, hemodynamic
variables, and received treatment during admission for
this cohort. Figure 4 demonstrates how during treatment,
PVR decreases (0.20±0.12 to 0.16±0.07 mm Hg∙s–1·mL–1,
P=0.002; 270±165 to 211±88 dynes·s–1·cm–5) and how
PAC increases even more (1.6±0.64 to 2.61±1.42 mL/mm
Hg, P<0.0001), resulting in a higher pulmonary arterial
time constant τ in most patients (0.29±0.12 to 0.37±0.15,
P<0.0001).

Discussion
The key ﬁnding of this study is that PAC, an integrated measure of RV afterload, may be superior to PVR in explaining
RV failure and in predicting adverse outcomes in the setting

Figure 2. Pulmonary arterial time constant as a function of
wedge pressure. The pulmonary arterial time constant τ (second) is the product of the pulmonary vascular resistance (PVR),
expressed in mm Hg·s–1·mL–1, times pulmonary arterial capacitance expressed in ml/mm Hg. Spearman’s correlation coefﬁcient between wedge pressure and time constant is −0.42.
The pulmonary arterial time constant is predicted by the formula
τ=0.52–0.0085×wedge pressure.

of left-sided heart failure. The reason for this resides in the
quality of PAC to combine the effects of PVR and PCWP on
RV afterload. Furthermore, treatment with intensive medical
therapy is associated with a favorable shift in PAC.
The afterload concept is daily used by clinicians while
treating patients with left-, right- or biventricular failure.
Although conceptualized as the load the ventricle experiences during contraction, afterload is much more difﬁcult
to measure and quantify. Pressures do not account for ﬂow
and because the heart is a pulsatile, and not a continuousﬂow pump, resistance is not sufﬁcient to describe afterload.
The most widely accepted model to describe the hydraulic
afterload is the so-called 3-element windkessel model which
combines the resistance (R) of the small arteries and arterioles with the elastic properties (compliance or capacitance
[C]) of the whole arterial system and with the characteristic impedance (Z) of the blood and proximal artery.18,19
PVR bundles R and Z and is the most often used measure
of RV afterload in clinical practice. The attraction of this
model lies in the fact that the parameters are fairly easy to

Figure 3. Clinical outcomes according to PAC and PVR quartiles. A, According to PAC quartiles. B, According to PVR quartiles.
C, According to PCWP quartiles. Log-rank <0.0001 for both. PAC indicates pulmonary arterial capacitance; PVR, pulmonary vascular
resistance; PCWP, pulmonary capillary wedge pressure.

Dupont et al
Table 3. Multivariate Cox Proportional Hazard Model For
Death or Transplantation

Pulmonary Arterial Capacitance in HF

Table 4. Demographics, Hemodynamics, and Medical
Treatment of 75 Patients Admitted With ADHF

Hazard Ratio* forDeath
or Transplant

P

NYHA (class)

1.09 (0.85–1.40)

0.50

Age, y

Age, y

0.97 (0.92–1.16)

0.53

Sex (% male)

Fick, L·min–1·m–2

0.56 (0.44–0.72)

<0.0001

PAC, mL/mm Hg

0.92 (0.84–1.0)

0.037

Body mass index, kg/m2

Predictors

783

Treatment Cohort (n=75)
Baseline clinical data
57±13
78

Ischemic pathogenesis, %

47
29±6

RV function (class)

1.18 (1.06–1.31)

0.0019

Diabetes mellitus, %

44

eGFR, mL·min–1·1.73 m–2

0.90 (0.85–0.94)

<0.0001

Left ventricular EF, %

24±13

When PAC was exchanged for PVR in this model, the P-value of PVR was
only 0.69.
NYHA indicates PAC, pulmonary arterial capacitance; RV, right ventricular;
eGFR, estimated glomerular ﬁltration rate.
*Hazard ratio per 1 increment for NYHA class, Fick index, PAC and RV
function. Per 10 increment for age and eGFR.

measure, have physiologic meaning, and are straightforward
to interpret.
The capacitance or compliance of the pulmonary circulation
is dependent on vessel wall elasticity but also on vessel wall
diameter and the latter in an exponential way. In other words,
when the diameter of the pulmonary vessels increases,
compliance will decrease to a much larger aspect. In addition
and different from the systemic circulation, compliance is
distributed over the entire pulmonary arterial bed owing to the
large number of peripheral vessels. The latter 2 particularities
form the base of the constant product of PVR and PAC
(pulmonary arterial time constant τ) between individuals and
during treatment observed in PAH patients.14 Indeed, whenever
PVR increases, elevations in intravascular pressure will result,
leading to stiffer arteries and reduced compliance. Even so, when
part of the pulmonary arterial tree is lost because of an embolus,
resistance will increase and compliance will decrease.20 This
interdependence of PVR and PAC is different from the systemic
circulation where resistance and compliance are anatomically
more separated and can evolve independent from each other (eg,
systolic hypertension of the elderly attributable to a decrease in
compliance of the proximal arteries).
In contrast to PAH, where an increase in PVR constitutes
the primary pathology, elevations in PVR are only optional in
left-sided heart failure and the result of either vasoconstriction or smooth muscle proliferation secondary to elevated leftsided ﬁlling pressures (backward failure). Also in contrast to
PAH, wedge pressure is highly variable within and between
patients, changes during treatment, and is a major determinant
of pulmonary intravascular pressure and consequently of PAC.
Because increases in wedge pressure lower PAC but do not
necessarily increase PVR, the pulmonary arterial time constant
decreases with increasing wedge pressure. The hyperbolic
relationship between PVR and PAC is still recognized, but the
exact position is dependent on wedge pressure (Figure 1).
We hypothesize that the observed superior prognostic ability of PAC over PVR is explained by the representation of
2 hemodynamic effects (those of PVR and wedge pressure)
in 1 measure, namely PAC. This adds to the classic explanation in PAH, where PAC is believed to be more sensitive
especially early in the disease process when small increases

Atrial ﬁbrillation, %

28

Baseline hemodynamic data
Heart rate baseline, bpm

87±18

Mean arterial pressure baseline, mm Hg

82±13

Mean RA pressure baseline, mm Hg

18±6

Mean PA pressure baseline, mm Hg

43±9

PCWP baseline, mm Hg

31±7

Fick cardiac index baseline, L·min–1·m–2

1.84±0.64

Follow-up hemodynamic data
Heart rate FU, bpm

86±15

Mean arterial pressure FU, mm Hg

75±8

Mean RA pressure FU, mm Hg

9±9

Mean PA pressure FU, mm Hg

29±6

PCWP FU, mm Hg

16±5

Fick cardiac index FU, L·min ·m
–1

–2

2.67±0.83

Medications
ACE inhibitor or ARBs, %

72

β-blockers, %

72

Loop diuretics, %

99

Aldosterone antagonists, %

56

Nitroprusside, %

75

Hydralazine, %

74

Isosorbide dinitrate, %

66

Milrinone, %

28

Dobutamine, %

24

IABP, %

7

Device data
ICD, %

59

CRT-D, %

21

Laboratory data
Creatinine, mg/dL

1.52±0.69

ADHF indicates acute decompensated heart failure; EF, ejection fraction; RA,
right atrial; PA, pulmonary arterial; PCWP, pulmonary capillary wedge pressure;
FU, follow-up (time of catheter removal); ACE, angiotensin-converting enzyme;
ARB, angiotensin receptor blocker; IABP, intra-aortic balloon pump; ICD, implantable cardioverter-deﬁbrillator; CRT-D, cardiac resynchronization therapy
with deﬁbrillator.

in PVR result in large decreases in PAC.11,14 Because the heart
failure population is very heterogeneous, the absolute strength
of outcome prediction of PAC is less evident than in the PAH
population where patients mainly die from RV failure.
The overall better performance of PAC does not alter
the speciﬁc importance of increased PVR in a subgroup of

Figure 4. PAC, PVR, and τ before and after treatment for acute decompensated heart failure. A, PVR and PAC before (open box) and
after treatment (closed box). Because PCWP decreases, the shift in PVR and PAC does not completely follow the original hyperbola. B,
Pulmonary arterial time constant increases in patients whose PCWP decreases (>10 mm Hg) during treatment. PAC indicates pulmonary
arterial capacitance; PVR, pulmonary vascular resistance; PCWP, pulmonary capillary wedge pressure.

patients. It was recently demonstrated that patients with
reactive or so-called out-of-proportion pulmonary hypertension (deﬁned as mPAP>25 mm Hg, PCWP>15 mm Hg and
PVR>3WU) have a particularly worse prognosis.10 Moreover,
the passive (increase in wedge pressure) component to RV
afterload is more easily correctable by medical treatment or
even heart transplantation than the reactive component. PVR
will keep playing an important role, for example in determining eligibility for heart transplantation.
The above discussion concentrated on how PAC is
inﬂuenced by increased vessel wall diameter because of either
increased PVR or wedge pressure. The question remains how
the quality of the vessel wall itself inﬂuences PAC and whether
interindividual variations are clinically meaningful as is the case
in the systemic circulation. The remarkable consistency and
similarity of τ in patients with PAH made authors believe that
there is little or no structural change in the elastic properties of
the pulmonary arterial circulation.13 Very recently, Tedford et
al17 found a small but signiﬁcant inﬂuence of age on τ . There is
indeed some evidence that structural changes in the pulmonary
arterial circulation occur with increasing age.21,22 Similar to our
study, they found a very signiﬁcant inﬂuence of PCWP on τ, a
relationship described by the formula τ=0.46–0.0063×wedge
pressure which is remarkably similar than the formula found in
the present study (τ=0.52–0.0085×wedge pressure). However,
in our study, there is still considerable variation in τ for every
given wedge pressure (see ﬁgure 2) which might be explained
in part by inaccurate measurements (eg, catheter wip), the
effect of large v-waves on the wedge pressure (calculated as the
integrated mean) and age, as discussed. In addition it remains
possible that other unappreciated factors inﬂuence the inverse
PVR–PAC relationship. The ﬁnding that PCWP augments the
pulsatile load on the afterload-sensitive right ventricle and
that this translates in more RV failure and ultimately worse
outcomes may serve as an extra argument to screen for and
treat elevated ﬁlling pressures.

Study Limitations
This study has several limitations. First, it is a retrospective
study with well-known inherent limitations. Second, we arbitrarily deﬁned a reasonable time frame with regard to clinical, laboratory, and echocardiographic data in relation to the
catheterization procedure. Third, there are currently no gold
standard for RV dysfunction, and in our paper this was adjudicated by a very crude visual echocardiographic assessment,
while other commonly described echocardiographic estimates
of RV function (such as tricuspid annular plane systolic excursion) were not available. However, if incorrectly done it would
likely attenuate the association with RV afterload measures
and therefore weaken our results. Moreover, despite the rough
nature of this assessment, RV failure remained one of the
strongest prognostic factors, even after multivariate adjustment. We were also unable to determine whether treatment
that does not directly alter pulmonary vascular tone has any
effect on PAC because treatment goals of reducing PCWP
were achieved by a variety of medications and procedures.
Finally, the hemodynamic values were obtained from the electronic medical record because original tracings were not available for retrospective analyses, and oxygen consumption rates
were assumed rather than measured. Nevertheless, we believe
that the high standard of care in a catheterization laboratory
run by cardiologists specialized in heart failure should limit
misinterpretation or inaccuracy in measurements.

Conclusion
We conclude that in heart failure with reduced ejection fraction, RV afterload is best represented by PAC because this
measure combines a hyperbolic inverse relationship with
PVR with a linear inverse relation with wedge pressure. These
properties account for its superior predictive ability. PAC is an
independent predictor of all-cause mortality and heart transplantation in this patient group and is modiﬁable by therapy.
Further prospective studies are needed to determine the practical utility and implications of this ﬁnding.
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CLINICAL PERSPECTIVE
In heart failure with reduced ejection fraction, right ventricular afterload is difﬁcult to quantify and appreciate. Pulmonary
arterial capacitance (PAC) is an integrated measure of right ventricular afterload that combines a hyperbolic inverse relationship with pulmonary vascular resistance with a linear inverse relation with wedge pressure. In our large series of patients
with advanced heart failure, we observed incremental prognostic value of PAC reduction with adverse long-term outcomes,
and improvement in PAC after vasodilator therapy in decompensated states. These ﬁndings validated the clinical relevance
of PAC, and support the evolving concept of reserve in right ventricular forward ﬂow that may provide a more integrated
view of ventricular interdependence at the bedside. Improvement in PAC with vasodilator therapy further illustrates the
importance of maintaining or improving PAC rather than simply focusing on lowering either pressure or resistance.
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